IP Library Assignment 047973/0110
Patent Assignment
Reel/Frame 047973/0110

Intellectual Property Security Agreement

Recorded: 2018-12-20 Pages: 42
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2018-12-20
Assignee
HERCULES CAPITAL, INC.
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties (25)
Mutilin Derivatives and Their Use as Antibacterials
Patent: 6,784,193 →
Application: 10/048,438 →
Pleuromutilin Derivatives Having Antibacterial Activity
Patent: 6,753,445 →
Application: 10/339,611 →
Publication: US 2003/0162831
Antibacterial Mutilins
Patent: 7,169,804 →
Application: 10/363,840 →
Publication: US 2004/0102482
Use of Pleuromutilins for the Treatment of Disorders Caused by Helicobacter Pylori
Patent: 7,790,749 →
Application: 10/510,532 →
Publication: US 2005/0131023
Pleuromutilin Derivatives as Antimicrobials
Patent: 7,612,103 →
Application: 10/521,926 →
Publication: US 2005/0250811
Mutilin Derivatives and Their Use as Antibacterials
Patent: 7,534,814 →
Application: 10/867,232 →
Publication: US 2004/0235910
Antibacterial Mutilins
Patent: 7,569,587 →
Application: 11/652,812 →
Publication: US 2007/0135483
Pleuromutilin Derivatives Containing a Hydroxyamino- or Acyloxyaminocycloalkyl Group
Patent: 7,790,767 →
Application: 11/814,672 →
Publication: US 2009/0306203
Organic Compounds
Patent: 7,816,389 →
Application: 11/814,673 →
Publication: US 2008/0287442
Tuberculosis Treatment Using Pleuromutilin Derivatives
Patent: 8,088,823 →
Application: 11/818,094 →
Publication: US 2007/0270404
Organic Compounds
Patent: 8,343,972 →
Application: 11/997,637 →
Publication: US 2008/0306072
Process for the Preparation of Pleuromutilins
Patent: 8,334,389 →
Application: 12/444,330 →
Publication: US 2009/0253748
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Patent: 8,071,643 →
Application: 12/531,839 →
Publication: US 2010/0035987
Organic Compounds
Patent: 9,061,980 →
Application: 12/668,690 →
Publication: US 2010/0190855
Pleuromutilin Derivatives and Their Use as Antimicrobials
Patent: 8,173,685 →
Application: 12/668,769 →
Publication: US 2010/0197734
Organic Compounds
Patent: 8,222,447 →
Application: 13/061,692 →
Publication: US 2011/0184022
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Patent: 8,153,689 →
Application: 13/252,732 →
Publication: US 2012/0029072
Substituted Clavulanic Acid
Patent: 9,120,808 →
Application: 13/395,606 →
Publication: US 2012/0232047
Pleuromutilins and Process for the Preparation of Pleuromutilins
Patent: 8,624,033 →
Application: 13/662,063 →
Publication: US 2013/0053571
Enantiomerically Pure Amines
Patent: 8,987,498 →
Application: 13/699,585 →
Publication: US 2013/0072711
Process for the Preparation of Pleuromutilins
Patent: 9,120,727 →
Application: 13/699,589 →
Publication: US 2013/0079400
Pleuromutilin Derivatives for Use in the Treatment of Diseases Mediated by Microbes
Patent: 9,278,920 →
Application: 13/821,446 →
Publication: US 2013/0274329
12-Epi Pleuromutilins
Patent: 9,701,628 →
Application: 15/111,390 →
Publication: US 2016/0332963
Injectable Pharmaceutical Formulations of Lefamulin
Application: 15/736,865 →
Publication: US 2018/0360966
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application: 16/023,880 →
Publication: US 2018/0303842
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0007 →
Assignment of Assignor's Interest Jan 17, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018783/0780 →
Assignment of Assignor's Interest Feb 22, 2007
From: ASCHER, GERD; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018931/0846 →
Assignment of Assignor's Interest Mar 1, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018955/0941 →
Assignment of Assignor's Interest Mar 20, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019046/0854 →
Assignment of Assignor's Interest Mar 21, 2007
From: BERNER, HEINZ; KERBER, GABRIELE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019049/0959 →
Change of Name Apr 6, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE GMBH)
To: SANDOZ GMBH
Reel/Frame 019132/0047 →
Assignment of Assignor's Interest Jun 13, 2007
From: ASCHER, GERD; BERNER, HEINZ; MANG, ROSEMARIE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019479/0230 →
Assignment of Assignor's Interest Nov 15, 2007
From: MANG, ROSEMARIE; ASCHER, GERD; FERENCIC, MATHIAS; HEILMAYER, WENER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0912 →
Assignment of Assignor's Interest Nov 15, 2007
From: THIRRING, KLAUS; ASCHER, GERD; PAUKNER, SUSANNE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0910 →
Assignment of Assignor's Interest May 12, 2008
From: MANG, ROSEMARIE; BERNER, HEINZ
To: NABRIVA THERAPEUTICS AG
Reel/Frame 020933/0554 →
Change of Name Aug 11, 2008
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021371/0769 →
Assignment of Assignor's Interest Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Assignment of Assignor's Interest May 15, 2009
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 022691/0682 →
Assignment of Assignor's Interest Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest Jan 29, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023873/0791 →
Assignment of Assignor's Interest Mar 11, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 024069/0305 →
Assignment of Assignor's Interest Apr 11, 2011
From: MANG, ROSEMARIE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 026105/0458 →
Assignment of Assignor's Interest Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Security Interest Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Lien Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Lien Sep 5, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033694/0165 →
Change of Name Sep 24, 2014
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033813/0230 →
Security Interest Sep 26, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033833/0311 →